For most women, the risk of developing ovarian cancer is low – only about 1.3 percent will get that diagnosis in their lifetime, according to the National Cancer Institute. Unfortunately, however, ovarian cancer often isn’t caught at early stages, making … Read more
It is fitting that a Food and Drug Administration alert this week about tests marketed for ovarian cancer screening came out in September, which President Bill Clinton declared in 1998 to be National Ovarian Cancer Awareness Month.
The FDA’s “safety … Read more
A new class of drugs could be a significant step forward in the treatment of ovarian cancer, one of the most lethal forms of the disease. The drugs, known as PARP inhibitors, are thought to help the body slow the … Read more
Call it luck — or a medical miracle. During clinical trials for experimental cancer drugs, some patients simply respond better than others. And a tiny fraction of patients see dramatic results, responding so well to treatment that they survive forms … Read more
With cancer, there are generally two scenarios – you either have it or you don’t. But I am somewhere in the middle, stuck inside a vortex. I don’t have cancer, but as a notable breast surgeon told me, “For you, … Read more
By: Annette McElhiney
Many factors contribute to ovarian cancer being such a difficult disease both to diagnose and to control. First, unlike breast cancer where mammograms can detect fully contained tumor, no specific test can detect the presence of ovarian … Read more
On Monday, the devastating news broke that screen icon and comedy trailblazer Gene Wilder has passed away. He was 83. Wilder’s nephew Jordan Walker-Pearlman confirmed to Variety that he died due to complications from Alzheimer’s disease. As we pay tribute … Read more
Use of a blood test in the monitoring of ovarian cancer patients who are in remission is an example of the “fatal attraction of more information” in medicine, according to an editorial published July 21 in JAMA Oncology.
The … Read more
When Sherry Pollex was diagnosed with stage three ovarian cancer at age 35, one doctor suggested she wouldn’t live more than a couple of years. But two years later, after beating that prognosis, she celebrated by launching SherryStrong.org — a … Read more
Buried in the fine print of many marketplace health plan documents is language that allows them to refuse to cover a range of services that are used more often by women, a study finds. It’s unclear if these exclusions have … Read more
With a unique approach that draws on 3-D printing technologies, a team of University of Wisconsin-Madison researchers is developing new tools for understanding how ovarian cancer develops in women.About 1.5 percent of American women will be diagnosed with ovarian cancer, … Read more
Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals, provide new research routes for scientists trying to detect … Read more
By: Annette McElhiney
Nemesis is defined as, “the inescapable agent of someone’s or something’s downfall.” This word seems perfect to characterize neuropathy as for many people with post chemo neuropathy, the condition literally causes us to take numerous, unwanted falls.… Read more
Government scientists are seeking a million volunteers willing to share the innermost secrets of their genes and daily lives as part of an ambitious 10-year research project to understand the causes and cures of disease.
Those selected to be members … Read more
Simplifying the way ovarian patients are tested is a “win-win” that saves both lives and money, a study shows. Testing their DNA should identify the most effective drugs and finds out if other family members are at risk.
Fewer than … Read more
Over the past 20 years, Nazneen Rahman has identified a steady stream of genes that influence the risk of breast, ovarian, and childhood cancers—work that has earned her scientific, popular, and even royal acclaim. But her latest accomplishment, and one … Read more
Promising new therapies are springing up to treat ovarian cancer, long one of the most deadly and hard to treat malignancies. The latest: An experimental drug from Tesaro, a small biotech company based in Waltham, Mass. The company on Wednesday … Read more
With the number of cancer survivors growing every day, the question of what to eat after a cancer diagnosis is quickly becoming a hot topic. Some survivors believe it is of little importance: they have already been through cancer, so … Read more
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more
By: Annette McElhiney
“Resilience presents a challenge for psychologists. Whether you can be said to have it or not largely depends not on any particular psychological test but on the way your life unfolds. If you are lucky enough to … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
